Suppr超能文献

寡脱氧核糖核苷酸活性的扩展序列偏好性。

Extended sequence preferences for oligodeoxyribonucleotide activity.

作者信息

Lenert Petar, Goeken Adam J, Ashman Robert F

机构信息

Division of Rheumatology, Department of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.

出版信息

Immunology. 2006 Apr;117(4):474-81. doi: 10.1111/j.1365-2567.2006.02320.x.

Abstract

Synthetic type B phosphorothioate oligodeoxyribonucleotides (ODN) activate mouse B cells via Toll-like receptor 9 (TLR9). Starting with closely related 15-mer prototype ODN, the sequence requirements for stimulatory (ST-) and inhibitory (IN-) activity were contrasted, by measuring apoptosis protection, G(1) entry and interleukin-6 secretion. ST-ODN and IN-ODN differ in that (1) ST-ODN require a 5' T, (2) the central CG is obligatory, (3) CG must be flanked 3' specifically by TT at the position where IN-ODN have GG, and (4) IN-ODN tolerate truncation of the 3' end better than ST-ODN. Features shared by ST-ODN and IN-ODN include (1) requiring CC adjacent to the 5' end, and (2) avoiding CC immediately 5' to the CG. This pattern is used to create a model of how ST-ODN binding might function to aggregate TLR9 so as to initiate the signal, and how the 5' ends of ST-ODN and IN-ODN compete for binding. Further justification for considering TLR9 to be the ODN receptor was provided by a demonstration that in HEK293 cells transfected with TLR9, the potency of a panel of ODN for activating NF-kappaB roughly parallels that seen in the biological assays in mouse B cells.

摘要

合成的B型硫代磷酸酯寡脱氧核糖核苷酸(ODN)通过Toll样受体9(TLR9)激活小鼠B细胞。从密切相关的15聚体原型ODN开始,通过测量细胞凋亡保护、G1期进入和白细胞介素-6分泌,对比了刺激(ST-)和抑制(IN-)活性的序列要求。ST-ODN和IN-ODN的不同之处在于:(1)ST-ODN需要一个5'端的T;(2)中间的CG是必需的;(3)CG在3'端必须特别地侧翼为TT,而在该位置IN-ODN具有GG;(4)IN-ODN比ST-ODN更能耐受3'端的截短。ST-ODN和IN-ODN共有的特征包括:(1)需要5'端相邻的CC;(2)避免CG紧邻5'端的CC。这种模式被用于建立一个模型,以解释ST-ODN结合可能如何聚集TLR9从而启动信号,以及ST-ODN和IN-ODN的5'端如何竞争结合。通过证明在转染了TLR9的HEK293细胞中,一组ODN激活NF-κB的效力大致与在小鼠B细胞的生物学测定中所见的效力平行,为将TLR9视为ODN受体提供了进一步的证据。

相似文献

8
DNA motifs suppressing TLR9 responses.抑制Toll样受体9反应的DNA基序
Crit Rev Immunol. 2006;26(6):527-44. doi: 10.1615/critrevimmunol.v26.i6.50.

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验